The Hyperphosphatemia Treatment Market Is Expected To Reach $5.5 Billion By 2026 Due To Increasing Cases Of Chronic Diseases As Per The Business Research Company’s Hyperphosphatemia Treatment Global Market Report 2022


LONDON, 19th May, 2022 (Globe Newswire) — Increasing chronic diseases among patients are driving the growth of the hyperphosphatemia treatment market, according to a business research company’s research report on the hyperphosphatemia treatment market. Chronic diseases are non-communicable and require long-term care. A vast majority of chronic diseases can be classified as cardiovascular diseases, chronic kidney disease, chronic respiratory conditions, hyperparathyroidism, diabetes and cancer. According to the World Health Organization (WHO), the prevalence of chronic disease is projected to increase by 57% by the year 2020. According to the United States Renal Data System, they estimate that there are more than 300,000 patients with end-stage kidney disease. United States. Patients with end-stage renal disease (ESRD) have increased hyperphosphatemia, thus contributing to increased hyperphosphatemia seeking treatment or drugs.

Demand for global samples hyperphosphatemia treatment market report

The size of the global hyperphosphatemia treatment market is expected to grow by From $3.22 billion in 2021 to $3.57 billion in 2022 at a compound annual growth rate (CAGR) 10.7%. Global hyperphosphatemia treatment market share is expected to grow $5.5 billion in 2026 on one 11.5% CAGR.

Increasing research and development activities are a major trend in the hyperphosphatemia treatment market. In hyperphosphatemia treatment, the company is focusing on R&D activities for the development of innovative therapies for the treatment of kidney diseases and related chronic conditions. For example, in May 2021, Shanghai-based biopharmaceutical company Aleband Pharmaceuticals raised $60 million in a Series B round to accelerate its development activities of innovative drugs and solutions for the treatment of kidney diseases, including hyperphosphatemia.

The major players in the hyperphosphatemia treatment market are Sanofi, Takeda Pharmaceutical Co. Ltd., Astellas Pharma Inc., Akebia Therapeutics, Inc., Vifor Pharma Management Ltd., Lupine Ltd., Ardelix, Inc., Unissive Therapeutics, Inc., Carex Biopharmaceuticals, Xyria. Pharmaceutical, Fresenius Medical Care, Shire, Ultragenex Pharmaceutical, Inc., Sun Pharmaceutical Industries, Ltd., Akebia Therapeutics, Inc., and AMAG Pharmaceuticals, Inc.

The global hyperphosphatemia treatment market analysis report is segmented by product into sevelamer, calcium-based phosphate binders, iron-based phosphate binders, lanthanum carbonate, among others; By distribution channel in hospital pharmacy, retail pharmacy, online store.

North America Was largest area In the hyperphosphatemia treatment market in 2021. Asia Pacific is expected to be fastest growing sector in the global hyperphosphatemia treatment market during the forecast period. area involved Global Hyperphosphatemia Treatment Market Outlook Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Hyperphosphatemia Treatment Global Market Report 2022 – Market Size, Trends, and Global Forecast 2022-2026 is a series of new reports from The Business Research Company that provides Hyperphosphatemia Treatment Market overview, analysis and forecast of market size and growth for the entire market does. Hyperphosphatemia Treatment Market Segment and Geographic, Hyperphosphatemia Treatment Market Trends, Hyperphosphatemia Treatment Market Drivers, Hyperphosphatemia Treatment Market Restrictions, Hyperphosphatemia Treatment Market Leading Competitors Revenue, Profile and Market Share in over 1,000 industry reports, over 2,500 market segments and 60 geographies covers areas.

The report also gives an in-depth analysis of the impact of COVID-19 on the market. The report is based on exclusive insights from 150,000 datasets, extensive secondary research and interviews with industry leaders. A highly experienced and expert team of analysts and modelers provide market analysis and forecasting. The report identifies top countries and regions for opportunities and strategies based on market trends and the outlook of major competitors.

Not the market you’re looking for? check out Some sSimilar Market intelligence report,

Cardiovascular Drugs Global Market Report 2022 – Type (Anti-Hypertensive Drugs, Hypolipidemics, Anti Thrombotics, Other Drugs for Cardiovascular Disease (Congestive Heart Failure, Anti-arrhythmic and Anti-anginal Drugs)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies) ) / drug store, other), by route of administration (oral, parenteral, other), by drug classification (branded drugs, generic drugs), by mode of purchase (prescription-based drugs, over-the-counter drugs) – market Size, Trends, and Global Forecast 2022-2026

Kidney Cancer Drugs Global Market Report 2022 – By Type (Renal Cell Carcinoma, Urothelial Carcinoma, Other (Renal Sarcoma, Renal Lymphoma)), By Product (Nexavar (sorafenib), Sutent (sunitinib), Afinitor (everolimus), Votrient (pazopanib) ), Avastin (bevacizumab), InLyta (axitinib), Torisel (temsirolimus), Proleukin (aldesleukin)), by end users (hospitals, clinics, research centers) – Market Size, Trends and Global Forecast 2022-2026

Diabetes Care Devices Global Market Report 2022 – By Type (Blood Glucose Test Strips, Insulin Pen, Syringe, Pump & Injector, Lensing Device & Equipment, Continuous Glucose Monitoring Equipment & Equipment, Blood Glucose Meter), By End User (Hospital & Clinic) , Diagnostic Laboratories, Other End Users), Expenditure Type (Public, Private), By Product (Equipment/Equipment, Disposable) – Market Size, Trends & Global Forecast 2022-2026

Interested in knowing more about the Business Research Company?

Business Research Company is a market intelligence firm that specializes in company, market and consumer research. Globally, it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals and technology.

The world’s most comprehensive database

Business Research The company’s flagship product, the Global Market Model, is a market intelligence platform covering a variety of macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model comprises of multilevel datasets that help its users to estimate the supply-demand gaps.

        

Stay Connected With Us On Social Media Platforms For Instant Updates Click Here To Connect With Us TeaveterAnd Facebook

we are on now wire. Click here to join our channel (@TechiUpdate) And stay updated with the latest technology headlines.

for all the latest Health News Click Here

Follow us on Google News for the latest news and updates,

read original article here

Denial of responsibility! NewsAzi is an automated aggregator around global media. All the material is available free of cost on the internet. We have arranged it on one platform only for educational purpose. In each material, a hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all content belongs to their authors. If you are the owner of the content and do not want us to publish your content on our website, please contact us E-mail - [email protected], Content will be removed within 24 hours.

Post The hyperphosphatemia treatment market is expected to reach $5.5 billion by 2026, according to the business research company's Hyperphosphatemia Treatment Global Market Report 2022 due to rising cases of chronic diseases. first appeared news,





Source link

Leave a Comment